Want to join the conversation?
$MRK said that the US Food and Drug Administration has granted Breakthrough Therapy Designation to KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma. The company stated that this is the fourth Breakthrough Therapy Designation granted for KEYTRUDA.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.